Issue
71
Co-proxamol and suicide
Restriction of availability of means
for suicide is a key strategy for its prevention. This approach has
been shown to be effective by the reduction in deaths after recent
UK legislation that reduced the
pack sizes of analgesics and previous restriction
on
prescribing toxic sedatives.
Co-proxamol is a prescription-only
analgesic that combines paracetamol and dextropropoxyphene.
Respiratory depression and consequent death may occur with overdose
due to ingestion of excessive dextropropoxyphene. Concern about the
number of such deaths was expressed by the BMJ as long ago as 1980.
A recent BMJ paper examined the
incidence of suicides due to co-proxamol compared with tricyclic
antidepressants and paracetamol, and to compare fatality rates for
self-poisonings with these drugs.
The study looked at routinely
collected national and local data on suicides and self poisonings
and records
of suicides in England and Wales 1997-9; non-fatal self poisonings
in Oxford District 1997-9.
Data sources used were the
Office for National Statistics and Oxford monitoring system
for attempted suicide. The incidence of
suicides with co-proxamol or tricyclic antidepressants or
paracetamol was measured as were the ratios
of fatal to non-fatal self poisonings.
Co-proxamol alone accounted for 5%
of all suicides. Of 4162 drug related suicides, 18% (766) involved
co-proxamol alone, 22% (927) tricyclic antidepressants alone, and 9%
(368) paracetamol alone. A higher proportion of suicides in the
10-24 year age group were due to co-proxamol than in the other age
groups. The odds of dying after overdose with co-proxamol was 2.3
times (95% confidence interval 2.1 to 2.5) that for tricyclic
antidepressants and 28.1 times (24.9 to 32.9) that for paracetamol.
They concluded that self poisoning
with co-proxamol is particularly dangerous and contributes
substantially to drug related suicides. Restricting availability for
co-proxamol could have an important role in suicide prevention.
Ref: web
Back to top
Counselling in primary care
This Cochrane Review searched 10
electronic databases, hand-searched specialist journals, as well as
consulting experts. The updated review used six databases, including
specialist trials registers. Randomised and controlled trials were
eligible that tested the hypothesis that counsellors treating
patients in primary care are more effective than usual care provided
by the GP or alternative mental health treatments.
Participants were patients consulting a GP with
psychological or psychosocial problems. Intervention by a counsellor
was undefined other than counsellors had to have been trained to the
British standard for accreditation. Outcomes measured were clinical
effectiveness of psychological outcomes like depressive symptoms and
measures of social function.
Seven trials were included from 12
publications, with 444 patients given counselling and 297 given
usual care. On a quality scoring system all scored reasonably well,
but how many of these trials were randomised or used blinded outcome
assessments is not mentioned in this review.
With counselling there was a small
increase in the percentage of patients having a reliable and
clinically meaningful change over the short term (under 9 months).
It is relevant to compare the weight
and quality of evidence we have here with the weight and quality of
evidence we expect from a newly introduced pharmacological therapy.
The trials say nothing about possible harms. For instance, might
there be rare but serious harm from counselling that outweighs any
possible small benefit?
Ref:web
Back to top
New Guidelines from NICE
Three new sets of guidelines came
out from NICE at the end of June: on preoperative testing, head
injury and infection control. Two are briefly mentioned here.
The National Institute for Clinical
Excellence has issued guidance on when to use routine preoperative
tests in elective surgery, according to the type of surgery planned,
patient’s age, and co-morbidity.
The guidance is designed to ensure
that preoperative tests are carried out systematically in all
hospitals in England and Wales on the basis of risk assessment.
It makes recommendations about the
appropriateness of carrying out simple tests such as plain chest
radiography, resting electrocardiography, full blood count,
haemostasis, renal function, and blood glucose.
These are tabulated on "look-up"
charts where the need for a particular test is assessed according to
the complexity of surgery, the patient’s age, and comorbidity. There
is very little evidence on the impact of preoperative testing on
outcomes, so a consensus approach was using in developing the
guidance, involving two parallel groups of experts in the field to
achieve robust decisions.
Around five million elective
surgical procedures are carried out each year by the NHS in England.
Many hospitals test patients before surgery for a range of
conditions that might affect their treatment. However, the number
and type of tests performed vary considerably.
Prompt assessment, early computed
tomography (CT), and better access to rehabilitation for patients
with minor injuries are key recommendations in national guidelines
on head injury published.
The National Institute for Clinical
Excellence (NICE) guidance also makes evidence based recommendations
on the management of patients with head injury, defined as any
trauma to the head, other than superficial injuries to the face;
from initial assessment through to hospital discharge and
rehabilitation.
The guidance recommends that all
patients presenting to emergency departments with a head injury
should be triaged by a trained member of staff within 15 minutes of
arrival. Patients should be assessed and classified using the
Glasgow coma scale and its derivative, the Glasgow coma score.
Patients should get imaging early,
rather than admission and observation for neurological
deterioration, the guidance proposes. CT imaging of the head is
recommended as the primary investigation of choice for the detection
of acute, clinically important brain injuries.
Head Injury: Triage, Assessment,
Investigation and Early Management and preoperative testing are
available or copies can be ordered from the NHS Response Line, tel
0870 1555 455.
Ref:web
Back to top
|